408 related articles for article (PubMed ID: 16282380)
1. Cost effectiveness analysis of strategies to combat HIV/AIDS in developing countries.
Hogan DR; Baltussen R; Hayashi C; Lauer JA; Salomon JA
BMJ; 2005 Dec; 331(7530):1431-7. PubMed ID: 16282380
[TBL] [Abstract][Full Text] [Related]
2. Cost effectiveness analysis of strategies for tuberculosis control in developing countries.
Baltussen R; Floyd K; Dye C
BMJ; 2005 Dec; 331(7529):1364. PubMed ID: 16282379
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of improved treatment services for sexually transmitted diseases in preventing HIV-1 infection in Mwanza Region, Tanzania.
Gilson L; Mkanje R; Grosskurth H; Mosha F; Picard J; Gavyole A; Todd J; Mayaud P; Swai R; Fransen L; Mabey D; Mills A; Hayes R
Lancet; 1997 Dec 20-27; 350(9094):1805-9. PubMed ID: 9428251
[TBL] [Abstract][Full Text] [Related]
4. Cost effectiveness of single-dose nevirapine regimen for mothers and babies to decrease vertical HIV-1 transmission in sub-Saharan Africa.
Marseille E; Kahn JG; Mmiro F; Guay L; Musoke P; Fowler MG; Jackson JB
Lancet; 1999 Sep; 354(9181):803-9. PubMed ID: 10485721
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of voluntary HIV-1 counselling and testing in reducing sexual transmission of HIV-1 in Kenya and Tanzania.
Sweat M; Gregorich S; Sangiwa G; Furlonge C; Balmer D; Kamenga C; Grinstead O; Coates T
Lancet; 2000 Jul; 356(9224):113-21. PubMed ID: 10963247
[TBL] [Abstract][Full Text] [Related]
6. Cost effectiveness of strategies to combat cardiovascular disease, diabetes, and tobacco use in sub-Saharan Africa and South East Asia: mathematical modelling study.
Ortegón M; Lim S; Chisholm D; Mendis S
BMJ; 2012 Mar; 344():e607. PubMed ID: 22389337
[TBL] [Abstract][Full Text] [Related]
7. Cost effectiveness analysis of strategies for maternal and neonatal health in developing countries.
Adam T; Lim SS; Mehta S; Bhutta ZA; Fogstad H; Mathai M; Zupan J; Darmstadt GL
BMJ; 2005 Nov; 331(7525):1107. PubMed ID: 16282407
[TBL] [Abstract][Full Text] [Related]
8. Cost effectiveness of strategies to combat chronic obstructive pulmonary disease and asthma in sub-Saharan Africa and South East Asia: mathematical modelling study.
Stanciole AE; Ortegón M; Chisholm D; Lauer JA
BMJ; 2012 Mar; 344():e608. PubMed ID: 22389338
[TBL] [Abstract][Full Text] [Related]
9. Cost and cost-effectiveness of a universal HIV testing and treatment intervention in Zambia and South Africa: evidence and projections from the HPTN 071 (PopART) trial.
Thomas R; Probert WJM; Sauter R; Mwenge L; Singh S; Kanema S; Vanqa N; Harper A; Burger R; Cori A; Pickles M; Bell-Mandla N; Yang B; Bwalya J; Phiri M; Shanaube K; Floyd S; Donnell D; Bock P; Ayles H; Fidler S; Hayes RJ; Fraser C; Hauck K;
Lancet Glob Health; 2021 May; 9(5):e668-e680. PubMed ID: 33721566
[TBL] [Abstract][Full Text] [Related]
10. Cost effectiveness of strategies to combat breast, cervical, and colorectal cancer in sub-Saharan Africa and South East Asia: mathematical modelling study.
Ginsberg GM; Lauer JA; Zelle S; Baeten S; Baltussen R
BMJ; 2012 Mar; 344():e614. PubMed ID: 22389347
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of HIV/AIDS interventions in Africa: a systematic review of the evidence.
Creese A; Floyd K; Alban A; Guinness L
Lancet; 2002 May; 359(9318):1635-43. PubMed ID: 12020523
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of environmental-structural communication interventions for HIV prevention in the female sex industry in the Dominican Republic.
Sweat M; Kerrigan D; Moreno L; Rosario S; Gomez B; Jerez H; Weiss E; Barrington C
J Health Commun; 2006; 11 Suppl 2():123-42. PubMed ID: 17148102
[TBL] [Abstract][Full Text] [Related]
13. Cost effectiveness of strategies to combat vision and hearing loss in sub-Saharan Africa and South East Asia: mathematical modelling study.
Baltussen R; Smith A
BMJ; 2012 Mar; 344():e615. PubMed ID: 22389341
[TBL] [Abstract][Full Text] [Related]
14. National and provincial estimated costs and cost effectiveness of a programme to reduce mother-to-child HIV transmission in South Africa.
Wilkinson D; Floyd K; Gilks CF
S Afr Med J; 2000 Aug; 90(8):794-8. PubMed ID: 11022629
[TBL] [Abstract][Full Text] [Related]
15. Cost effectiveness of targeted HIV prevention interventions for female sex workers in India.
Prinja S; Bahuguna P; Rudra S; Gupta I; Kaur M; Mehendale SM; Chatterjee S; Panda S; Kumar R
Sex Transm Infect; 2011 Jun; 87(4):354-61. PubMed ID: 21447514
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of male circumcision for HIV prevention in a South African setting.
Kahn JG; Marseille E; Auvert B
PLoS Med; 2006 Dec; 3(12):e517. PubMed ID: 17194197
[TBL] [Abstract][Full Text] [Related]
17. Determining a cost effective intervention response to HIV/AIDS in Peru.
Aldridge RW; Iglesias D; Cáceres CF; Miranda JJ
BMC Public Health; 2009 Sep; 9():352. PubMed ID: 19765304
[TBL] [Abstract][Full Text] [Related]
18. Cost effectiveness analysis of strategies to combat malaria in developing countries.
Morel CM; Lauer JA; Evans DB
BMJ; 2005 Dec; 331(7528):1299. PubMed ID: 16282381
[TBL] [Abstract][Full Text] [Related]
19. Are targeted HIV prevention activities cost-effective in high prevalence settings? Results from a sexually transmitted infection treatment project for sex workers in Johannesburg, South Africa.
Vickerman P; Terris-Prestholt F; Delany S; Kumaranayake L; Rees H; Watts C
Sex Transm Dis; 2006 Oct; 33(10 Suppl):S122-32. PubMed ID: 16735954
[TBL] [Abstract][Full Text] [Related]
20. Cost effectiveness of strategies to combat neuropsychiatric conditions in sub-Saharan Africa and South East Asia: mathematical modelling study.
Chisholm D; Saxena S
BMJ; 2012 Mar; 344():e609. PubMed ID: 22389339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
